Bayer and Asklepios BioPharmaceutical (AskBio) have announced FDA fast track des...
Pan Cancer T has announced a €4.25m ($4.62m) seed extension round to complete of...
The cash injection will accelerate the development of Crossject’s prefilled need...
AusperBio Therapeutics and Ausper Biopharma have received breakthrough therapy d...
Research suggests biomanufacturing specialists remain nervy about global supply ...
BioArctic has announced that its partner, Eisai has approval from Hong Kong's De...
Rgenta has secured approval for its IND application for RGT-61159, an oral small...
Preclinical biopharmaceutical company Tiba Biotech has announced a partnership w...
J&J gains Phase II ready NM26, a bispecific antibody in development for the trea...
The deal strengthens Merz’s market position in Parkinson’s disease whilst expand...
Novo Nordisk-partnered Aspect develops bioprinted tissue therapeutics designed t...
The company did not expect to resolve concerns related to manufacturing and the ...
Boehringer Ingelheim’s For Generations framework is all in on sustainability for...
The Association of the British Pharmaceutical Industry (ABPI) also called out No...
China's NMPA approved Antengene’s new indication of XPOVIO for adults with relap...
iOnctura will evaluate roginolisib in combination with GSK’s Jemperli in a Phase...
